Xenon Pharmaceuticals Inc.
Solid state forms of spiro-oxindole compounds

Last updated:

Abstract:

The present invention provides solid state forms of certain spiro-oxindole compounds, such as funapide and the racemic mixture of funapide and its corresponding (R) enantiomer, pharmaceutical compositions comprising the solid state forms and processes for preparing the solid state forms and the pharmaceutical compositions.

Status:
Grant
Type:

Utility

Filling date:

10 Oct 2018

Issue date:

24 Dec 2019